explore -WSS

explore

author：explore 2025-09-29 19:58:21 - browse：1

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Plastic surgeons increase patient psychiatric screenings

WSS

BD to buy Edwards patient monitoring unit for $4.2 billion

Intermittent fasting comes with a heart risk? Not so fast

Baby aspirin cuts fat buildup in liver disease patients, in small study

FTC loses bid to block Novant's North Carolina hospital merger

U.K. researchers warn about biases in medical devices, algorithms

FTC loses bid to block Novant's North Carolina hospital merger

explore

explore

explore

Affirmative action in medical school literally saved lives

Congress needs to close a vaccine

Sports medicine is finally prioritizing gender equality

STAT wants to know your pick for a great summer read or listen

New air purifier tech could be key to improving indoor air quality

Data don't support strong claims for Covid

Hollywood unions extend contract negotiations for actors

ASCO Takeaways: Winners, snoozers, and the art of cancer care

New air purifier tech could be key to improving indoor air quality

CMS got Medicare Advantage quality rating wrong, judge rules

explore

Medicare Advantage's lean provider networks lead CMS complaints

FTC loses bid to block Novant's North Carolina hospital merger

Congress needs to close a vaccine

SCOTUS questions limit to govt efforts to fight misinformation

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

focus

focus

knowledge